首页> 外文期刊>Acta Cardiologica >Usefulness of myocardial necrosis triad markers for predicting 4-year mortality in patients with suspected acute coronary syndrome.
【24h】

Usefulness of myocardial necrosis triad markers for predicting 4-year mortality in patients with suspected acute coronary syndrome.

机译:心肌坏死三联征标志物可用于预测可疑急性冠脉综合征患者的4年死亡率。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Cardiac troponins (cTn), creatine kinase-MB (CK-MB), myoglobin (MYO) are commonly used biochemical markers for risk stratification and diagnosis in patients with suspected acute coronary syndrome (ACS). The aim of the study was to analyse the prognostic implications of 3 myocardial necrosis markers measured at admission in the long-term observation. METHODS: The study group consisted of 336 consecutive patients whose concentration of cTnl, CK-MB and MYO were measured at admission. Patients were categorized into 4 groups according to the number of positive myocardial necrosis markers. RESULTS: There was a significant increase in the mean marker levels with increasing numbers of positive markers (over upper normal range): cTnl (0.02 +/- 0.06; 0.7 +/- 1.9; 3.4 +/- 8.8; 5.1 +/- 9.2 ng/ml; P < 0.001), CK-MB (1.3 +/- 1.1; 3.3 +/- 3.9; 21.9 +/- 39.4; 37.5 +/- 48.4 ng/ml; P < 0.001), MYO (39.4 +/- 16.5; 94.5 +/- 91; 202.2 +/- 172.2; 320.3 +/- 234.3 ng/ml; P < 0.001). There was a statistically significant increase in the 4-year all-cause mortality with increasing numbers of positive markers; P value for trend < 0.0001. CONCLUSIONS: All 3 marker levels at admission may be an important addition to the risk stratification of patients with suspected ACS and a potentially important target for therapy. They have prognostic implications in the long-term observation of patients with chest pain and suspected ACS.
机译:目的:心肌肌钙蛋白(cTn),肌酸激酶-MB(CK-MB),肌红蛋白(MYO)是可疑急性冠脉综合征(ACS)患者危险分层和诊断的常用生化标志物。该研究的目的是分析长期观察时在入院时测量的3种心肌坏死标志物的预后意义。方法:研究组由336名连续患者组成,他们在入院时测量了cTnl,CK-MB和MYO的浓度。根据阳性的心肌坏死标记物的数量将患者分为4组。结果:随着阳性标志物数量的增加(超过正常范围上限),平均标志物水平显着增加:cTnl(0.02 +/- 0.06; 0.7 +/- 1.9; 3.4 +/- 8.8; 5.1 +/- 9.2 ng / ml; P <0.001),CK-MB(1.3 +/- 1.1; 3.3 +/- 3.9; 21.9 +/- 39.4; 37.5 +/- 48.4 ng / ml; P <0.001),MYO(39.4 + / -16.5; 94.5 +/- 91; 202.2 +/- 172.2; 320.3 +/- 234.3 ng / ml; P <0.001)。随着阳性标记物数量的增加,四年全因死亡率在统计学上有显着增加。趋势的P值<0.0001。结论:入院时所有3种标记物水平可能是对疑似ACS患者的危险分层的重要补充,也是治疗的潜在重要目标。在长期观察胸痛和疑似ACS的患者中,它们具有预后意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号